Prophylactic Ranibizumab for Exudative Age-Related Macular Degeneration
Clinical trial NCT02302989 · COMPLETED
Trial details
- NCT number
- NCT02302989
- Sponsor
- Leonard Feiner, MD, PhD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2018-07-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.